About Irving Weissman
Irving Weissman is a director at Pheast Therapeutics.
Irving Weissman first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Irving Weissman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Irving Weissman works with at each company, as listed on that company's latest Form D.
Pheast Therapeutics, Inc. · Form D, Oct 16, 2025
RM
Roy Maute
CEO and director
RR
Raphael Rousseau
Executive officer
SG
Steven Gillis
Director
JV
Jacob Vogelstein
Director
AB
Amira Barkal
Director
TM
Thomas Marty
Executive officer